High prevalence of anti-SARS-CoV-2 antibodies after the first wave of COVID-19 in Kinshasa, Democratic Republic of the Congo: results of a cross-sectional household-based survey.
Antoine N NkubaSheila M MakialaEmilande GuichetPaul M TshiminyiYannick M BazitamaMarc K YambayambaBenito M KazenzaTrésor M KabeyaElysee B MatunguluLionel K BaketanaNaomi M MitongoGuillaume ThaurignacFabian H LeendertzVeerle VanlerbergheRaphaël PelloquinJean-François EtardDavid MamanPlacide K MbalaAhidjo AyoubaMartine PeetersJean-Jacques T MuyembeEric DelaporteSteve M AhukaPublished in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2021)
The prevalence of SARS-CoV-2 is much higher than the number of COVID-19 cases reported. These results justify the organization of a sequential series of serosurveys by public health authorities to adapt response measures to the dynamics of the pandemic.